Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use
Top Cited Papers
- 30 June 2007
- journal article
- practice guideline
- Published by Elsevier BV in European Journal Of Cancer
- Vol. 43 (9), 1348-1360
- https://doi.org/10.1016/j.ejca.2007.03.021
Abstract
No abstract availableThis publication has 91 references indexed in Scilit:
- The TP53 Colorectal Cancer International Collaborative Study on the Prognostic and Predictive Significance of p53 Mutation: Influence of Tumor Site, Type of Mutation, and Adjuvant TreatmentJournal of Clinical Oncology, 2005
- Systemic Therapy for Colorectal CancerThe New England Journal of Medicine, 2005
- A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast CancerThe New England Journal of Medicine, 2004
- Tumor markers and colorectal cancer: Utility in managementJournal of Surgical Oncology, 2003
- American Society of Clinical Oncology Policy Statement Update: Genetic Testing for Cancer SusceptibilityJournal of Clinical Oncology, 2003
- Clinical utility of biochemical markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelinesEuropean Journal of Cancer, 2003
- Kirsten ras mutations in patients with colorectal cancer: the ‘RASCAL II’ studyBritish Journal of Cancer, 2001
- Current treatment for colorectal cancer metastatic to the liverEuropean Journal of Surgical Oncology, 1999
- Risk of hepatoblastoma in familial adenomatous polyposisThe Journal of Pediatrics, 1991
- The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC)Diseases of the Colon & Rectum, 1991